Does SARS-CoV-2 bind to human ACE2 stronger than SARS-CoV?
The 2019 novel coronavirus (SARS-CoV-2) epidemic, which was first reported in December 2019 in Wuhan, China, was declared a pandemic by the World Health Organization in March 2020. Genetically, SARS-CoV-2 is closely related to SARS-CoV, which caused a global epidemic with 8096 confirmed cases in mor...
Hlavní autoři: | Nguyen, HL, Lan, PD, Thai, NQ, Nissley, DA, O'Brien, EP, Li, MS |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
American Chemical Society
2020
|
Podobné jednotky
-
The evolution of SARS-CoV-2
Autor: Markov, PV, a další
Vydáno: (2023) -
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
Autor: Kim, KS, a další
Vydáno: (2021) -
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
Autor: Suryamohan, Kushal, a další
Vydáno: (2022) -
Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
Autor: Barton, MI
Vydáno: (2022) -
The SARS-CoV-2 variants and their impacts
Autor: Akmal Shukri, Amir Muhaimin, a další
Vydáno: (2022)